Ozempic and Smell: Sensitivity, Food Aversion, Urine and Body Odor

No GLP-1 label lists a change in the sense of smell, and the two studies that tested smell directly in people taking these drugs found no significant loss.^[6][7] A records study of 438,474 matched pairs with type 2 diabetes did find more diagnoses of smell disturbance on GLP-1 drugs, at 1.81 times the rate of other diabetes drugs.^[1] That is a real signal, but it is a diagnosis code, not a smell test. How the body itself smells is thinner still. One published case ties a GLP-1 drug to body odor.^[19] The likelier routes are indirect: darker, stronger urine when you drink less, and fasting breath or ketones when you eat very little.

The short answer, question by question

Does Ozempic change your sense of smell?

Start with the labels. None of the four main labels mentions smell, odor, parosmia or anosmia anywhere in the text. What they do list is dysgeusia, the medical term for a distorted or unpleasant taste. Taste and smell are easy to confuse because most of what people call flavor is actually smell, so a complaint about food may be either.

“In clinical trials in adults for weight reduction, 1.7% of WEGOVY-treated patients and 0.5% of placebo-treated patients reported dysgeusia.”^[2]

— Wegovy prescribing information, adverse reactions (DailyMed)

Two studies have actually put a smell test in front of people taking these drugs. At the University of Pennsylvania, 46 users and 46 matched controls took a 40-item scratch-and-sniff identification test and a taste test. Taste scores were markedly lower in the GLP-1 group. Smell scores were slightly lower on average, but the difference did not reach statistical significance (p = 0.076).^[6] The senior author owns the company that makes both tests, which the paper discloses. At Purdue, 79 adults with obesity were compared before starting, at one month and at six months on a GLP-1 drug. Olfactory function was largely unchanged; the clearest difference was a higher threshold for detecting sweetness.^[7]

An older study points the other way. Twenty people with obesity and type 2 diabetes scored better on a smell test after three months of GLP-1 treatment, though that part of the study had no comparison group.^[8] Put together, direct testing has not shown that these drugs blunt the sense of smell.

The records study is the strongest evidence that something is going on. Using electronic health records from 2017 to 2026, researchers matched 438,474 adults with type 2 diabetes who started a GLP-1 drug to the same number who started other diabetes drugs. Over up to two years, the GLP-1 group was more likely to receive a diagnosis code for a smell disturbance (hazard ratio 1.81) or a taste disturbance (1.52).^[1] The authors themselves call for validation. Two limits matter for a reader. The study covered only type 2 diabetes, not people using Wegovy or Zepbound for weight alone. And a diagnosis code records that someone raised a complaint, not what a smell test would show. A plausible reading, and it is only inference, is that people on these drugs notice and report smell changes more than their test scores move.

A single case report illustrates that gap. A 41-year-old woman on semaglutide for 24 weeks reported smell discomfort near the top of a 50-point scale, with parosmia, meaning familiar smells come across distorted or unpleasant. Her scores on a standard smell test did not change.^[12] She was also taking naltrexone/bupropion, a second weight-loss drug, so semaglutide cannot be singled out.

What FDA adverse-event reports show

Two analyses of FDA’s adverse-event reporting system found more reports of smell problems with GLP-1 drugs than the database average: parosmia across the class,^[9] and anosmia, the loss of smell, with semaglutide.^[10] These are reporting signals. They show a term is reported more often than expected, not how often it happens or that the drug caused it. Anyone can file a report, and publicity drives filing.

Even the largest smell term, parosmia, appears in about one semaglutide report in a thousand.^[11] Small numbers like these cannot be turned into a risk.

Why a GLP-1 could touch smell: the olfactory bulb (animal research)

The idea is not far-fetched, but the evidence for it comes from animals. In rats, the gene for the GLP-1 receptor is active in the mitral cell layer of the olfactory bulb, the first relay station for smell signals in the brain.^[13] In mouse brain slices, GLP-1 and the drug exendin-4 made those mitral cells fire more often, and the authors suggested that smell coding could shift with feeding state.^[14] In live mice, blocking GLP-1 receptors in the bulb stopped lean mice from foraging by smell, and an agonist restored foraging in obese mice.^[15] Semaglutide also reduced how strongly tiny worms moved toward an attractive odor.^[16]

None of this shows what a weekly injection does to human smell. No study has measured how much semaglutide or tirzepatide reaches the human olfactory bulb. The closest human data are brain scans: in a 16-week trial in people with type 2 diabetes, liraglutide increased a memory region’s response to odors.^[17] That is a measure of brain activity, not of what a person can smell.

When food smells turn unpleasant

Many people describe the smell of certain foods, often fried or greasy food, becoming off-putting. No study has measured food-odor aversion on these drugs directly. What has been measured is close to it. In a 12-week crossover trial, people on semaglutide ate 24% less across the day, reported fewer cravings and showed a lower preference for high-fat foods. Nausea ratings were similar to placebo in that trial, and the only meal rated less palatable was the taste of one lunch.^[18] At six months, GLP-1 users in the Purdue study reported lower food reward and weaker responses to food cues.^[7]

Nausea is the other likely piece. On the Wegovy label, 44% of people reported nausea, against 16% on placebo,^[2] and strong smells are a common nausea trigger. That link has not been tested on these drugs, so treat it as inference. The appetite side of this is covered in what food noise is, and the semaglutide taste trial in taste got better, not worse.^[30]

Does a GLP-1 change how your body smells?

No label lists body odor, sweat odor or urine odor as a side effect; the only mention of sweating is as a sign of low blood sugar. The published record holds one case. A 57-year-old man with type 2 diabetes developed a body odor that family and coworkers noticed two weeks after starting dulaglutide (Trulicity). Tests ruled out infection and metabolic causes. The odor cleared about ten days after he stopped, came back when he restarted, and did not return after he switched to semaglutide.^[19] Stopping and restarting is the strongest kind of evidence a single case can give, but it is still one person, on a drug most readers are not taking.

Adverse-event reports of abnormal skin, urine and breath odor exist for semaglutide and tirzepatide, in the dozens (see the table above).^[11] Nothing in them explains a cause. The more plausible explanations are the indirect ones below.

Stronger-smelling urine: less fluid in

GLP-1 drugs reduce drinking as well as eating. In rats, they suppress water intake even when no food is present.^[21] In people, the best evidence is a small placebo-controlled crossover trial: 20 healthy volunteers on dulaglutide for three weeks drank a median of 1,300 mL during an eight-hour test day against 1,600 mL on placebo, a difference that fell just short of significance. Their 24-hour urine output was lower, 1,250 mL against 1,680 mL, and they did not feel any less thirsty.^[20] In the semaglutide trial above, thirst ratings were similar to placebo too.^[18] That combination matters: the usual cue to drink may not fire.

Less urine means more concentrated urine. Urine color tracks body water about as well as lab measures of concentration,^[23] and the National Library of Medicine notes that urine from a body low on fluids can smell like ammonia.^[22] Its list of other causes is worth knowing on these drugs:

• Ammonia smell, dark color: concentrated urine from low fluid intake.^[22]
• Foul smell, especially with burning or fever: possible urinary tract infection.^[22]
• Sweet or fruity smell: ketones in the urine, or blood sugar that is not controlled.^[22]

“Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration.”^[5]

— Ozempic patient information (DailyMed); the same wording appears on the Wegovy, Mounjaro and Zepbound labels

The labels carry a warning for kidney injury from fluid loss, mostly in people who were vomiting or had diarrhea.^[2] Strong-smelling urine on its own is not that. Very little urine, dizziness on standing, or being unable to keep fluids down is. Our water intake calculator gives a daily target, and GLP-1 drugs and your kidneys explains the warning.

Breath and sweat: what eating very little does

When food intake drops far enough, the body burns more fat and makes ketones. One of them, acetone, leaves through the breath, and breath acetone rises with ketosis about as reliably as urine ketones do.^[24] It ranges from about 1 ppm in people who are not dieting to 1,250 ppm in diabetic ketoacidosis.^[25] The sweet note of ketotic breath has been described for centuries.^[26] Fasting itself also changes breath: in 36 people who fasted for about ten days, a sulfur compound called dimethylsulfide rose, matching the bad breath that fasting is known for.^[27]

None of this has been measured in people taking a GLP-1. It is a reasonable inference that someone eating a few hundred calories a day on one of these drugs could have the same breath changes as someone fasting. The same goes for sweat. No study has tied ketones to sweat odor in GLP-1 users, and claims online that they do are guesses. If your intake has fallen that low, the breath is the least of the problems: see eating too little on a GLP-1.

Sulfur burps and vaginal odor

The rotten-egg burps many people notice are covered in burping, reflux and gas on a GLP-1, including what the labels say about burping. Changes in vaginal odor, and what usually causes them, are covered in vaginal dryness, odor and infections on a GLP-1.

What to do, and when to call

• Smell distorted or food smells repellent: worth mentioning to your prescriber, but not urgent. No study has tracked how long smell changes last; how long the stomach side effects usually last is covered in our side-effect timeline.
• Smell suddenly gone, or a smell of something that is not there: see a doctor. Loss of smell has many causes unrelated to these drugs, and it should not be assumed to be the medicine.
• Dark, strong urine: drink more, spread through the day, without waiting for thirst.^[20]
• Foul urine with burning, fever or back pain: get checked for a urinary infection.^[22]
• Body odor that started with a new drug: keep a note of timing. In the one published case the odor tracked the drug exactly.^[19]
• Fruity breath with vomiting or belly pain: urgent care, especially if you cannot keep fluids down.^[28]